Evidence map›Paper›PMID 26029163›Full record

ReviewFrontiers in endocrinology2015

Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine Disruptors.

Marina Grimaldi, Abdelhay Boulahtouf, Vanessa Delfosse, Erwan Thouennon, William Bourguet, Patrick Balaguer

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Marina GrimaldiIRCM, Institut de Recherche en Cancérologie de Montpellier , Montpellier , France ; U1194, INSERM , Montpellier , France ; Université Montpellier , Montpellier , France ; ICM, Institut Régional du Cancer de Montpellier , Montpellier , France.
Abdelhay BoulahtoufIRCM, Institut de Recherche en Cancérologie de Montpellier , Montpellier , France ; U1194, INSERM , Montpellier , France ; Université Montpellier , Montpellier , France ; ICM, Institut Régional du Cancer de Montpellier , Montpellier , France.
Vanessa DelfosseUniversité Montpellier , Montpellier , France ; U1054, INSERM , Montpellier , France ; CNRS UMR5048, Centre de Biochimie Structurale , Montpellier , France.
Erwan ThouennonIRCM, Institut de Recherche en Cancérologie de Montpellier , Montpellier , France ; U1194, INSERM , Montpellier , France ; Université Montpellier , Montpellier , France ; ICM, Institut Régional du Cancer de Montpellier , Montpellier , France.
William BourguetUniversité Montpellier , Montpellier , France ; U1054, INSERM , Montpellier , France ; CNRS UMR5048, Centre de Biochimie Structurale , Montpellier , France.
Patrick BalaguerIRCM, Institut de Recherche en Cancérologie de Montpellier , Montpellier , France ; U1194, INSERM , Montpellier , France ; Université Montpellier , Montpellier , France ; ICM, Institut Régional du Cancer de Montpellier , Montpellier , France.
Institut Regional du Cancer de MontpellierCentre de Biologie Structurale · FRInserm · FRInstitut de Recherche en Cancérologie de Montpellier · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine-disrupting chemicals (EDCs) are exogenous substances interfering with hormone biosynthesis, metabolism, or action, and consequently causing disturbances in the endocrine system. Various pathways are activated by EDCs, including interactions with nuclear receptors (NRs), which are primary targets of numerous environmental contaminants. The main NRs targeted by environmental contaminants are the estrogen (ER α, β) and the androgen (AR) receptors. ERs and AR have pleiotropic regulatory roles in a diverse range of tissues, notably in the mammary gland, the uterus, and the prostate. Thus, dysfunctional ERs and AR signaling due to inappropriate exposure to environmental pollutants may lead to hormonal cancers and infertility. The pregnane X receptor (PXR) is also recognized by many environmental molecules. PXR has a protective role of the body through its ability to regulate proteins involved in the metabolism, the conjugation, and the transport of many exogenous and endogenous compounds. However, the permanent activation of this receptor by xenobiotics may lead to premature drug metabolism, the formation, and accumulation of toxic metabolites and defects in hormones homeostasis. The activity of other NRs can also be affected by environmental molecules. Compounds capable of inhibiting or activating the estrogen related (ERRγ), the thyroid hormone (TRα, β), the retinoid X receptors (RXRα, β, γ), and peroxisome proliferator-activated (PPAR α, γ) receptors have been identified and are highly suspected to promote developmental, reproductive, neurological, or metabolic diseases in humans and wildlife. In this review, we provide an overview of reporter cell lines established to characterize the human NR activities of a large panel of EDCs including natural as well as industrial compounds such as pesticides, plasticizers, surfactants, flame retardants, and cosmetics.

Indexed as

environmental-disrupting compoundsnuclear receptorsreporter cell lines

Identifiers

PMID26029163
PMCPMC4426785
OpenAlexW1587496812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.